VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
96 hedge funds and large institutions have $27.9M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 20 increasing their positions, 34 reducing their positions, and 20 closing their positions.
Holders
96
Holders Change
-18
Holders Change %
-15.79%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
20
Reduced
34
Closed
20
Calls
$75K
Puts
$2K
Net Calls
+$73K
Net Calls Change
-$71K
Top Buyers
| 1 |
1
Bank of America
Charlotte,
North Carolina
|
$131K |
| 2 |
2
Morgan Stanley
New York
|
$90.3K |
| 3 |
3
JPMorgan Chase & Co
New York
|
$110K |
| 4 |
4
Renaissance Technologies
New York
|
$242K |
| 5 |
5
Barclays
London,
United Kingdom
|
$30K |
Top Sellers
| 1 |
1
BlackRock
New York
|
$3.87M |
| 2 |
2
Millennium Management
New York
|
$5K |
| 3 |
E
3
Ergoteles
New York
|
$0 |
| 4 |
HF
4
HRT Financial
New York
|
$0 |
| 5 |
5
Jane Street
New York
|
$6.56K |
